Uniminoxidil Tablet
Minoxidil 5mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
MFDS item code 202102018 · Notified 2021.03.04
This product's status changed to Approval withdrawn on 2024.09.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension (including refractory and symptomatic hypertension)
This drug is used in the treatment of hypertension caused by symptomatic or specific organ damage, and in refractory hypertension that cannot be controlled with diuretics and two other antihypertensive agents.
1. Adults (12 years and older): The initial dose is 5㎎ of minoxidil orally once daily. The maintenance dose is 10-40㎎ daily, administered in 1- several divided doses. A maximum of 100㎎ daily may be administered. 3. Frequency of administration: During treatment with this medicine, the magnitude of fluctuations in arterial blood pressure over the day is proportional to the amount of blood pressure reduction. If the reduction in diastolic blood pressure is less than 30mmHg, once-daily administration may be used; if the reduction in diastolic blood pressure is 30mmHg or greater, administer in 2 divided doses daily. 4. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days as a general rule, since an adequate response to a dose may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while the patient is carefully monitored. 5. Concomitant administration 1) Diuretics: This medicine is coadministered with a diuretic in patients who rely on renal function to maintain salt and water balance. It has been coadministered with the following diuretics: ① Hydrochlorothiazide (50㎎ per dose, twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose, once daily) ③ Furosemide (40㎎ per dose, twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, change the diuretic to furosemide; if the patient is already receiving furosemide, increase the dose as needed. 2) β-blockers or other sympatholytic agents: During treatment with this medicine, administer a β-blocker in divided doses equivalent to 80-160㎎ of propranolol daily. If β-blockers are contraindicated, methyldopa (250-750㎎ per dose, twice daily) may be given instead. Because methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. Sympatholytic agents may not completely block the increase in heart rate caused by this medicine, but they can generally prevent tachycardia. Patients receiving a β-blocker before starting therapy with this medicine typically have bradycardia; their heart rate is expected to increase to normal after this medicine is administered. When this medicine is coadministered with a β-blocker or another sympatholytic agent, the opposing effects on the heart offset each other, resulting in little change in heart rate. Adjust the dose appropriately according to age and symptoms.
2. Children (12 years and under): The initial dose is 0.2㎎ per ㎏ of body weight once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎ per ㎏ of body weight daily. A maximum of 50㎎ daily may be administered.
This drug should not be administered to certain patients. In patients with pheochromocytoma, this drug may increase the amount of hormones secreted by the tumor due to its blood pressure-lowering effects, therefore it should be avoided. Patients with pulmonary hypertension due to mitral stenosis, patients with acute myocardial infarction, and those who have experienced allergic reactions to this drug should also not be administered this medication. In patients with chronic congestive heart failure, severe renal impairment, and angina, additional caution is necessary when using this drug. Using this drug may commonly lead to abnormal hair growth as a side effect. This phenomenon typically begins around the face and head and may spread to other areas of the body; when the medication is discontinued, new hair growth stops, but it takes time to return to the original condition. Also, skin rashes or blisters may occur, and severe allergic reactions should be watched for skin changes. Blood tests may show a decrease in platelet or white blood cell counts, and liver function test results may change. Electrocardiograms may show changes in the electrical signals of the heart, but in most cases, these return to normal with continued treatment. Pericardial effusion may rarely occur, particularly in patients with poor renal function. In such cases, the condition should be monitored via echocardiography, and additional treatment may be necessary as needed. Other rare side effects may include weight gain, peripheral edema, increased heart rate, gastrointestinal disturbances, breast pain, anemia, headache, nausea, and vomiting. Typically, this drug is used in conjunction with diuretics to prevent fluid retention and symptoms of heart failure, and weight and electrolyte status should be monitored regularly. Due to its vasodilatory effects, increased heart rate or angina symptoms may occur; therefore, it is common to use beta-blockers together to prevent these symptoms. Patients with decreased renal function or those undergoing dialysis may require dosage adjustments, and myocardial infarction patients should be administered after their condition is stabilized. At the beginning of treatment, it is important to regularly perform urine tests, renal function tests, electrocardiograms, chest X-rays, and echocardiograms. Caution is required when using this drug with others. In particular, concomitant use with guanethidine may cause severe hypotension; therefore, it should be avoided if possible, and if unavoidable, should be managed safely in a medical facility. Antidepressants or antipsychotics can increase the risk of hypotension, and concomitant use with corticosteroids or certain anti-inflammatory analgesics may increase fluid retention or reduce blood pressure-lowering effects. Safety has not been established during pregnancy, so use is not recommended, and during breastfeeding, there is a possibility that the drug may be passed into breast milk, so administration should be avoided or breastfeeding should be discontinued. There is limited experience with use in children, especially infants, so caution should be taken in administration. In the case of overdose, blood pressure may drop severely, so immediate medical assistance should be sought, and appropriate measures to stabilize blood pressure are necessary.
Hair growth, thickening, pigmentation increase, exudative rash, vesicular lesions, skin and mucous membrane syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, changes in ECG T-wave direction and amplitude, pericardial effusion, ischemia, weight gain, peripheral edema, increased heart rate, elevated creatinine, elevated BUN, gastrointestinal disturbances, rash, breast pain, gynecomastia, hemolytic anemia, pulmonary infiltration, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to prevent exposure to air or light and should be kept at room temperature between 1°C and 30°C. Proper storage like this can maintain the drug's effectiveness and prevent degradation.
White round tablet
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Minoxidil 5mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Minoxidil 5mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 3g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hanmi Pharmaceutical Co., Ltd.
Minoxidil 5g
Solution · OTC medication
JW Pharmaceutical Corp.
Minoxidil 3g
Solution · OTC medication
Haitai HTB Co., Ltd.
Minoxidil 5g
Solution · OTC medication
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.